I was unclear in what I wrote earlier, the section 15 was inserted not deleted. The latest markup which this came from was not yet up on the Vt legislative website but should be soon.<br><br><div class="gmail_quote">---------- Forwarded message ----------<br>
From: <b class="gmail_sendername">Stevan Gressitt</b> <span dir="ltr"><<a href="mailto:gressitt@gmail.com">gressitt@gmail.com</a>></span><br>Date: Fri, Mar 2, 2012 at 5:39 PM<br>Subject: Vermont<br>To: pharmwaste <<a href="mailto:pharmwaste@lists.dep.state.fl.us">pharmwaste@lists.dep.state.fl.us</a>><br>
<br><br><div>House and Senate still pending...this is a committee action</div><div><br></div><div><br></div><div>(Draft No. 1.2 – H.745) Page 1 of 20</div><div>3/1/2012 - JGC - 6:45 PM</div><div>VT LEG 277286.1</div><div>
TO THE HOUSE 1 OF REPRESENTATIVES:</div>
<div>2 The Committee on Human Services to which was referred House Bill</div><div>3 No. 745 entitled “An act relating to the Vermont prescription monitoring</div><div>4 system” respectfully reports that it has considered the same and recommends</div>
<div>5 that the bill be amended by striking out all after the enacting clause and</div><div>6 inserting in lieu thereof the following:</div><div><br></div><div>deleted material...</div><div><br></div><div><div>15 Sec. 15. UNUSED DRUG DISPOSAL PROGRAM</div>
<div>16 (a) The commissioner of health shall establish a program based on</div><div>17 Maine’s Safe Medicine Disposal for ME Program that enables Vermont</div><div>18 residents to safely dispose of unused or expired prescription and</div>
<div>19 over-the-counter medicine using free, postage-paid medicine disposal kits.</div><div>20 (b) The commissioner shall identify and secure appropriate sources of</div><div>21 funding to support the drug disposal program.</div>
</div><div><br></div><div><br></div><div><br></div>-- <br>Stevan Gressitt, M.D.<br>Faculty Associate, University of Maine Center on Aging<br>Academic Member, Athens Institute for Education and Research<br>Athens, Greece<br>
Founding Director, International Institute for Pharmaceutical Safety<br>University of New England, College of Pharmacy<br>Department of Pharmaceutical Sciences<br>Associate Professor of Clinical Psychiatry<br>University of New England, College of Osteopathic Medicine<br>
314 Clark Road<br>Unity, Maine, 04988<br><a href="mailto:gressitt@gmail.com" target="_blank">gressitt@gmail.com</a> <br>Cell: <a href="tel:207-441-0291" value="+12074410291" target="_blank">207-441-0291</a><br><a href="http://www.benzos.une.edu" target="_blank">www.benzos.une.edu</a><br>
<a href="http://www.safemeddisposal.com" target="_blank">www.safemeddisposal.com</a><br>
</div><br><br clear="all"><div><br></div>-- <br>Stevan Gressitt, M.D.<br>Faculty Associate, University of Maine Center on Aging<br>Academic Member, Athens Institute for Education and Research<br>Athens, Greece<br>Founding Director, International Institute for Pharmaceutical Safety<br>
University of New England, College of Pharmacy<br>Department of Pharmaceutical Sciences<br>Associate Professor of Clinical Psychiatry<br>University of New England, College of Osteopathic Medicine<br>314 Clark Road<br>Unity, Maine, 04988<br>
<a href="mailto:gressitt@gmail.com" target="_blank">gressitt@gmail.com</a> <br>Cell: 207-441-0291<br><a href="http://www.benzos.une.edu" target="_blank">www.benzos.une.edu</a><br><a href="http://www.safemeddisposal.com" target="_blank">www.safemeddisposal.com</a><br>